Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Definitive Healthcare Corp. DH | 0.00 | |
Dow Jones Industrial Average DJI | 0.00 | |
S&P 500 index SPX | 0.00 | |
NASDAQ IXIC | 0.00 |
FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeannine Lombardi, Definitive Healthcare’s new Chief Human Resource Officer, an inducement award consisting of 421,349 time-based restricted stock units (“RSUs”), and Jonathan Paris, Definitive Healthcare’s new Chief Legal Officer, an inducement award consisting of 421,349 time-based RSUs, each effective July 1, 2025. Each of these awards was individually negotiated and was granted as an inducement material to Ms. Lombardi’s and Mr. Paris’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Each of the awards is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant.
Ms. Lombardi’s and Mr. Paris’s RSUs will vest as follows, subject to their continued employment through each such date: (i) 25% will vest on July 1, 2026; (ii) the remainder will vest in quarterly installments equal to 6.25% of the total RSUs over the subsequent 3 years, until fully vested.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.
Investor Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com
646-277-1251
Media Contact:
Bethany Swackhamer
bswackhamer@definitivehc.com
![]()
Recommend
- Insights 10/11 08:34
Improved Revenues Required Before Viant Technology Inc. (NASDAQ:DSP) Stock's 29% Jump Looks Justified
Simply Wall St 12/11 11:21Will Robust Revenue Growth and Declining Margins Shift Shopify's (SHOP) Long-Term Investment Narrative?
Simply Wall St 12/11 13:24Viewbix Sells Cortex Media To Minute Media Subsidiary As It Expands Into Quantum Computing And AI; No Financial Terms Disclosed
Benzinga News 12/11 21:48Reported Earlier, BlackBerry Expands Partnership For Women In Cyber Leadership Program In Malaysia, Starting January 26 2026
Benzinga News Today 07:06JFrog Unveils Shadow AI Detection To Expose Enterprise AI Blind Spots And Strengthen Software Supply Chain Governance
Benzinga News Today 08:30Via Projects Q4 2025 Platform Revenue Of $114.6M To $115.1M With Adjusted EBITDA Loss Of $8.5M To $7.5M; FY 2025 Platform Revenue Of $430M To $430.5M And Adjusted EBITDA Loss Of $34.5M To $33.5M
Benzinga News Today 12:04Odysight ai Q3 EPS $(0.27) Misses $(0.11) Estimate, Sales $149.000K Miss $700.000K Estimate
Benzinga News Today 13:53


